Literature DB >> 26669358

Laparoscopic Versus Open Nephroureterectomy in Muscle-Invasive Upper Tract Urothelial Carcinoma: Subanalysis of the Multi-Institutional National Database of the Japanese Urological Association.

Jun Miyazaki1, Hiroyuki Nishiyama1, Hiroyuki Fujimoto2, Chikara Ohyama3, Takuya Koie3, Shiro Hinotsu4, Eiji Kikuchi5, Mizuaki Sakura6, Junichi Inokuchi7, Tomohiko Hara2.   

Abstract

OBJECTIVES: Open nephroureterectomy (ONU) is the current standard for muscle-invasive upper tract urothelial carcinoma (UTUC) in the European Association of Urology/Japanese Urological Association (JUA) guidelines. In this study, we compared the postsurgical survival of muscle-invasive UTUC patients treated with ONU or with laparoscopic nephroureterectomy (LNU), using the multi-institutional national database of the JUA.
METHODS: The 1509 patients with UTUC who were diagnosed at 348 Japanese institutions in 2005 were registered. We collected the clinical data of the patients in 2011. The muscle-invasive UTUC patients who underwent ONU or LNU were identified, and survival curves were estimated using the Kaplan-Meier method.
RESULTS: Overall, 749 pT2≥cNxM0 patients underwent a nephroureterectomy (ONU, n = 527 and LNU, n = 222). The overall survival and cause-specific survival rates were not significantly different between the ONU and LNU groups (p = 0.1263 and p = 0.0893, respectively). In addition, 459 of the 749 (61.3%) patients experienced disease recurrence (bladder recurrence, local recurrence, or distant metastasis), with no significant difference between the ONU and LNU groups. Even when patients were stratified by pT3/pT4 and/or pN+, overall survival was not significantly different between the ONU and LNU groups (p = 0.2876). The results of a univariate analysis showed that lymphovascular invasion was an independent prognostic factor for overall survival, but the surgical approaches were not found to be associated with overall survival.
CONCLUSIONS: Our data suggest that there is no evidence that the oncologic outcome of LNU is inferior to that of ONU in muscle-invasive UTUC, when the appropriate patients are selected.

Entities:  

Mesh:

Year:  2016        PMID: 26669358     DOI: 10.1089/end.2015.0757

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  13 in total

1.  Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Authors:  Koichi Kido; Shingo Hatakeyama; Naoki Fujita; Hayato Yamamoto; Yuki Tobisawa; Tohru Yoneyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Ikuya Iwabuchi; Masaru Ogasawara; Toshiaki Kawaguchi; Chikara Ohyama
Journal:  Int J Clin Oncol       Date:  2018-02-12       Impact factor: 3.402

2.  A New Surgical Technique of Combination Retroperitoneal with Transperitoneal Laparoscopic Nephroureterectomy in a Single Position and Comparative Outcomes.

Authors:  Liming Song; Wenkuan Wang; Qinxin Zhao; Yuhong Wen; Xiaoguang Zhou; Hu Han; Xiaodong Zhang
Journal:  Cancer Manag Res       Date:  2020-07-13       Impact factor: 3.989

3.  Impact of bacillus Calmette-Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy.

Authors:  Hirotaka Horiguchi; Takahiro Yoneyama; Shingo Hatakeyama; Noriko Tokui; Tendo Sato; Naoki Fujita; Hayato Yamamoto; Yuki Tobisawa; Tohru Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Kazuaki Yoshikawa; Satoshi Narita; Toshiaki Kawaguchi; Chikara Ohyama
Journal:  Med Oncol       Date:  2018-02-26       Impact factor: 3.064

4.  Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study.

Authors:  Yuka Kubota; Shingo Hatakeyama; Toshikazu Tanaka; Naoki Fujita; Hiromichi Iwamura; Jotaro Mikami; Hayato Yamamoto; Yuki Tobisawa; Tohru Yoneyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Hiroyuki Ito; Kazuaki Yoshikawa; Atsushi Sasaki; Toshiaki Kawaguchi; Chikara Ohyama
Journal:  Oncotarget       Date:  2017-10-06

Review 5.  Laparoscopic nephroureterectomy for upper tract urothelial carcinoma - Update.

Authors:  Victor C Lin; Chung-Hsien Chen; Allen W Chiu
Journal:  Asian J Urol       Date:  2016-05-26

6.  Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma.

Authors:  Hirotaka Horiguchi; Shingo Hatakeyama; Go Anan; Yuka Kubota; Hirotake Kodama; Masaki Momota; Koichi Kido; Hayato Yamamoto; Yuki Tobisawa; Tohru Yoneyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Hiroyuki Ito; Kazuaki Yoshikawa; Toshiaki Kawaguchi; Makoto Sato; Chikara Ohyama
Journal:  Oncotarget       Date:  2018-01-04

7.  Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Authors:  Masaki Momota; Shingo Hatakeyama; Hayato Yamamoto; Hiromichi Iwamura; Yuki Tobisawa; Tohru Yoneyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Ikuya Iwabuchi; Masaru Ogasawara; Toshiaki Kawaguchi; Chikara Ohyama
Journal:  Oncotarget       Date:  2018-05-01

Review 8.  Laparoscopic versus open nephroureterectomy for upper urinary tract urothelial carcinoma: A systematic review and meta-analysis.

Authors:  Feng Liu; Wei Guo; Xueying Zhou; Youpeng Ding; Yanan Ma; Yi Hou; Xiangbo Kong; Zhixin Wang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

9.  Long-term oncologic outcomes of laparoscopic nephroureterectomy versus open nephroureterectomy for upper tract urothelial carcinoma: a systematic review and meta-analysis.

Authors:  Su Zhang; You Luo; Cheng Wang; Sheng-Jun Fu; Li Yang
Journal:  PeerJ       Date:  2016-05-31       Impact factor: 2.984

10.  Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.

Authors:  Hirotake Kodama; Shingo Hatakeyama; Naoki Fujita; Hiromichi Iwamura; Go Anan; Ken Fukushi; Takuma Narita; Toshikazu Tanaka; Yuka Kubota; Hirotaka Horiguchi; Masaki Momota; Koichi Kido; Teppei Matsumoto; Osamu Soma; Itsuto Hamano; Hayato Yamamoto; Yuki Tobisawa; Tohru Yoneyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Hiroyuki Ito; Kazuaki Yoshikawa; Atsushi Sasaki; Toshiaki Kawaguchi; Makoto Sato; Chikara Ohyama
Journal:  Oncotarget       Date:  2017-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.